Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages 1289-1295

  Xu, Li Ming ^a   Li, Ye Xiong ^a   Fang, Hui ^a   Jin, Jing ^a   Wang, Wei Hu ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Song, Yong Wen ^a   Liu, Qing Feng ^a   Chen, Bo ^a   Qi, Shu Nan ^a   Ren, Hua ^a   Dai, Jian Rong ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE-VOLUME HISTOGRAMS; DOSIMETRIC PARAMETER; INTENSITY-MODULATED RADIATION THERAPY; METHODS AND MATERIALS; NORMAL STRUCTURE; PLANNING TARGET VOLUMES; SALVAGE RADIATION THERAPIES; TREATMENT OUTCOMES;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DOSIMETERS; DOSIMETRY; ONCOLOGY; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

DOXORUBICIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARGE CELL LYMPHOMA; LUNG VOLUME; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SALVAGE THERAPY; TOXICITY;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; FEMALE; HEART; HUMANS; LUNG; LYMPHOMA, B-CELL; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875253205     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.10.037     Document Type: Article

References (20)

1. D. Cazals-Hatem, E. Lepage, and P. Brice Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (Groupe d'Etude des Lymphomes de l'Adulte) study Am J Surg Pathol 20 1996 877 888
2. M. Rieger, A. Osterborg, and R. Pettengell Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study Ann Oncol 22 2011 664 670
3. P. Gaulard, N.L. Harris, and S.A. Pileri Primary mediastinal (thymic) large B-cell lymphoma E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues 2008 IARC Press Lyon, France 250 251
4. P.L. Zinzani, M. Martelli, and M. Bertini Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients Haematologica 87 2002 1258 1264
5. P.A. Hamlin, C.S. Portlock, and D.J. Straus Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999 Br J Haematol 130 2005 691 699
6. P.L. Zinzani, V. Stefoni, and E. Finolezzi Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study Clin Lymphoma Myeloma 9 2009 381 385
7. H.K. Ahn, S.J. Kim, and J. Yun Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients Int J Hematol 91 2010 456 463
8. T.P. Vassilakopoulos, G.A. Pangalis, and A. Katsigiannis Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care Oncologist 17 2012 239 249
9. J. Phan, A. Mazloom, and L.J. Medeiros Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy J Clin Oncol 28 2010 4170 4176
10. P. Dirix, B. Vanstraelen, and M. Jorissen Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy Int J Radiat Oncol Biol Phys 78 2010 998 1004
11. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
12. A. Paumier, M. Ghalibafian, and J. Gilmore Dosimetric benefits of intensity- modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 82 2012 1522 1527
13. J. Koeck, Y. Abo-Madyan, and F. Lohr Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy Int J Radiat Oncol Biol Phys 83 2012 268 276
14. N.N. Lu, Y.X. Li, and R.Y. Wu Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement Int J Radiat Oncol Biol Phys 84 2012 210 216
15. J. Yahalom, and P. Mauch The involved field is back: issues in delineating radiation field in Hodgkin's disease Ann Oncol 13 Suppl 1 2002 79 83
16. B.D. Cheson, S.J. Horning, and B. Coiffier Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol 17 1999 1244 1253
17. E.S. Koh, A. Sun, and T.H. Tran Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 66 2006 223 228
18. A.M. Fox, A.P. Dosoretz, and P.M. Mauch Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy Int J Radiat Oncol Biol Phys 83 2012 277 283
19. G. Rodrigues, M. Lock, and D. D'Souza Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review Radiother Oncol 71 2004 127 138
20. J.A. Dorth, L.R. Prosnitz, and G. Broadwater Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging Int J Radiat Oncol Biol Phys 84 2012 762 767